News
Prescribers invited to shape Active Ingredient Prescribing Program
AMA members are asked to participate in a survey for the Department of Health.
The Department of Health and Aged Care is seeking prescriber and other stakeholder feedback about the use of the List of Medicines for Brand Consideration (LMBC) as a support tool to prescribing by brand name in addition to active ingredient, under the Active Ingredient Prescribing (AIP) Program.
The survey is open until 13 November 2023 by clicking the following link: https://consultations.health.gov.au/technology-assessment-access-division/consultation-on-the-active-ingredient-prescribing
Questions about the survey (or the AIP program) can be directed to AIPrescribing@health.gov.au .
http://www.health.gov.au/our-work/active-ingredient-prescribing
